All Stories

  1. Duration of dual antiplatelet therapy after drug-eluting stent implantation: will we ever reach a consensus?

    Article • European Heart Journal, March 2015, European Society of Cardiology

    Professor Marco Valgimigli

  2. Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment Af...

    Article • European Heart Journal, February 2015, European Society of Cardiology

    Professor Marco Valgimigli

  3. Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program

    Article • American Heart Journal, December 2014, Elsevier

    Professor Marco Valgimigli

  4. Antiplatelet and anticoagulation agents in acute coronary syndromes: What is the current status and what does the future hold?

    Article • American Heart Journal, November 2014, Elsevier

    Professor Philippe Gabriel STEG, Professor Marco Valgimigli

  5. How can we optimize the processes of care for acute coronary syndromes to improve outcomes?

    Article • American Heart Journal, November 2014, Elsevier

    Professor Marco Valgimigli

  6. Randomized comparison between 3-month Cre8 DES vs. 1-month Vision/Multilink8 BMS neointimal coverage assessed by OCT evaluation: The DEMONSTRATE study

    Article • International Journal of Cardiology, October 2014, Elsevier

    Professor Marco Valgimigli

  7. TCT-645 Optical coherence tomography findings in bioresorbable scaffold thrombosis

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    Professor Marco Valgimigli

  8. Usefulness and Safety of Vorapaxar in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (from the TRACER Trial)

    Article • The American Journal of Cardiology, September 2014, Elsevier

    Professor Marco Valgimigli

  9. Randomized comparison of operator radiation exposure comparing transradial and transfemoral approach for percutaneous coronary procedures: rationale and design of the minimizing adverse haemorrhagic events by TRansradial access site and systemic implem...

    Article • Cardiovascular Revascularization Medicine, June 2014, Elsevier

    Professor Marco Valgimigli, Dr Alessandro Sciahbasi

  10. Stable Angina Pectoris

    Article • Current Atherosclerosis Reports, May 2014, Springer Science + Business Media

    Professor Marco Valgimigli

  11. Predicting 3-Year Mortality After Percutaneous Coronary Intervention

    Article • JACC Cardiovascular Interventions, May 2014, Elsevier

    Professor Marco Valgimigli

  12. Transradial Coronary Catheterization and Intervention Across the Whole Spectrum of Allen Test Results

    Article • Journal of the American College of Cardiology, May 2014, Elsevier

    Professor Marco Valgimigli

  13. Two-year outcomes after first- or second-generation drug-eluting stent implantation in patients with in-stent restenosis. A PRODIGY trial substudy

    Article • International Journal of Cardiology, May 2014, Elsevier

    Professor Marco Valgimigli

  14. Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial

    Article • European Heart Journal, April 2014, European Society of Cardiology

    Professor Marco Valgimigli

  15. PROGNOSTIC IMPLICATIONS OF SEVERE LESION CALCIFICATION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Professor Marco Valgimigli

  16. Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Ostial/Midshaft Lesions in Unprotected Left Main Coronary Artery From the DELTA Registry

    Article • JACC Cardiovascular Interventions, April 2014, Elsevier

    Professor Marco Valgimigli

  17. Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women–Drug-Eluting stent for LefT main coronary Artery disease ...

    Article • The American Journal of Cardiology, April 2014, Elsevier

    Professor Marco Valgimigli

  18. Tirofiban

    Article • March 2014, Wiley

    Professor Marco Valgimigli

  19. Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis

    Article • Journal of the American College of Cardiology, February 2014, Elsevier

    Professor Marco Valgimigli

  20. Long‐term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit‐only, immediate, or staged multivessel percutaneous revascularization strategies: Insights from the REAL registry

    Article • Catheterization and Cardiovascular Interventions, February 2014, Wiley

    Professor Marco Valgimigli

  21. Guía de Práctica Clínica de la ESC 2013 sobre diagnóstico y tratamiento de la cardiopatía isquémica estable

    Article • Revista Española de Cardiología, February 2014, Elsevier

    Professor Marco Valgimigli, Professor Raffaele Bugiardini

  22. Scientific Foundation and Possible Implications for Practice of the Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX (MATRIX) Trial

    Article • Journal of Cardiovascular Translational Research, January 2014, Springer Science + Business Media

    Professor Marco Valgimigli, Roberto Violini

  23. Two-Year Outcomes After First- or Second-Generation Drug-Eluting or Bare-Metal Stent Implantation in All-Comer Patients Undergoing Percutaneous Coronary Intervention

    Article • JACC Cardiovascular Interventions, January 2014, Elsevier

    Professor Marco Valgimigli

  24. Acute kidney injury after primary angioplasty

    Article • Journal of Cardiovascular Medicine, January 2014, Wolters Kluwer Health

    Professor Marco Valgimigli

  25. The EXAMINATION Trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction)

    Article • JACC Cardiovascular Interventions, January 2014, Elsevier

    Professor Marco Valgimigli

  26. Excimer Laser LEsion Modification to Expand Non-dilatable sTents: The ELLEMENT Registry

    Article • Cardiovascular Revascularization Medicine, January 2014, Elsevier

    Professor Marco Valgimigli

  27. Comparison of Newer-Generation Drug-Eluting With Bare-Metal Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction

    Article • JACC Cardiovascular Interventions, January 2014, Elsevier

    Professor Marco Valgimigli

  28. Meeting the Unmet – The Cre8 Polymer-free Drug-eluting Stents Technology

    Article • Interventional Cardiology Reviews Research Resources, January 2014, Medical Media Communications, Ltd. T/A Radcliffe Cardiology

    Professor Marco Valgimigli

  29. Identifying responsiveness to oral P2Y12 receptor blockers

    Article • Journal of Cardiovascular Medicine, December 2013, Wolters Kluwer Health

    Professor Marco Valgimigli

  30. Zotarolimus- Versus Everolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease

    Article • Journal of the American College of Cardiology, December 2013, Elsevier

    Professor Marco Valgimigli

  31. Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Ostial/Mid-Shaft Lesions Versus Distal Bifurcation Lesions in Unprotected Left Main Coronary Artery

    Article • JACC Cardiovascular Interventions, December 2013, Elsevier

    Professor Marco Valgimigli

  32. Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials

    Article • The Lancet, December 2013, Elsevier

    Professor Marco Valgimigli

  33. Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint ...

    Article • American Heart Journal, November 2013, Elsevier

    Professor Marco Valgimigli

  34. Comparison of Bivalirudin Versus Heparin(s) During Percutaneous Coronary Interventions in Patients Receiving Prasugrel: A Propensity‐Matched Study

    Article • Clinical Cardiology, October 2013, Wiley

    Professor Philippe Gabriel STEG, Professor Marco Valgimigli, Dr laurent bonello

  35. Benefits and risks of long-term duration of dual antiplatelet therapy after drug-eluting stenting: A meta-analysis of randomized trials

    Article • International Journal of Cardiology, October 2013, Elsevier

    Professor Marco Valgimigli

  36. TCT-242 Impact of gender on clinical outcome of everolimus-eluting stent versus bare-metal stent in patients with ST-elevation myocardial infarction.

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Professor Marco Valgimigli

  37. TCT-447 Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction. Insights from the EXAMINATION trial

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Professor Marco Valgimigli

  38. Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction

    Article • International Journal of Cardiology, October 2013, Elsevier

    Professor Marco Valgimigli

  39. 5-S-Lipoylhydroxytyrosol, a Multidefense Antioxidant Featuring a Solvent-Tunable Peroxyl Radical-Scavenging 3-Thio-1,2-dihydroxybenzene Motif

    Article • The Journal of Organic Chemistry, September 2013, American Chemical Society (ACS)

    Professor Marco Valgimigli, Professor Marco d'Ischia

  40. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients

    Article • International Journal of Cardiology, September 2013, Elsevier

    Professor Marco Valgimigli

  41. Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study)

    Article • The American Journal of Cardiology, September 2013, Elsevier

    Professor Marco Valgimigli

  42. Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis

    Article • International Journal of Cardiology, September 2013, Elsevier

    Professor Marco Valgimigli, Associate Prof Hasan Ari, Dr laurent bonello

  43. Clinical Outcomes With Drug-Eluting and Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction

    Article • Journal of the American College of Cardiology, August 2013, Elsevier

    Professor Marco Valgimigli, Dr Tullio Palmerini, Prof. Giuseppe Biondi-Zoccai

  44. Everolimus-eluting stent versus bare metal stent in proximal left anterior descending ST-elevation myocardial infarction

    Article • American Heart Journal, July 2013, Elsevier

    Professor Marco Valgimigli

  45. Prediction of 1-Year Mortality in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

    Article • JACC Cardiovascular Interventions, July 2013, Elsevier

    Professor Marco Valgimigli, Dr Tullio Palmerini

  46. Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction

    Article • Cardiovascular Research, June 2013, European Society of Cardiology

    Professor Marco Valgimigli

  47. Open-Label, Randomized, Placebo-Controlled Evaluation of Intracoronary Adenosine or Nitroprusside After Thrombus Aspiration During Primary Percutaneous Coronary Intervention for the Prevention of Microvascular Obstruction in Acute Myocardial Infarction

    Article • JACC Cardiovascular Interventions, June 2013, Elsevier

    Dr Italo Porto, Dr Enrico Romagnoli, Professor Marco Valgimigli

  48. Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY)

    Article • International Journal of Cardiology, April 2013, Elsevier

    Professor Marco Valgimigli

  49. DETERMINATION OF THE URINARY NEUTROPHIL GELATINASE–ASSOCIATED LIPOCALIN AS AN EARLY MARKER OF CONTRAST INDUCED ACUTE KIDNEY INJURY AFTER CORONARY CATHETERIZATION

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor Marco Valgimigli

  50. ARE “NEW GENERATION” DES SUPERIOR TO “OLD GENERATION” DES IN REDUCING ADVERSE CLINICAL OUTCOMES AT LONG–TERM FOLLOW–UP: INSIGHTS FROM REAL (REGISTRO REGIONALE ANGIOPLASTICHE DELL'EMILIA–ROMAGNA) MULTICENTER REGISTRY

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor Marco Valgimigli

  51. PREDICTION OF ONE-YEAR MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING PCI FROM THE ACUITY (ACUTE CATHETERIZATION AND URGENT INTERVENTION TRIAGE STRATEGY) TRIAL VALIDATION OF THE LOGISTIC CLINICAL SYNTAX SCORE

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor Marco Valgimigli, Dr Tullio Palmerini

  52. THE ROLE OF FEMALE SEX IN THE CONTEMPORARY TREATMENT OF THE LEFT MAIN CORONARY ARTERY INSIGHTS FROM THE W– DELTA (WOMEN– DRUG ELUTING STENT FOR LEFT MAIN CORONARY ARTERY DISEASE) REGISTRY

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor Marco Valgimigli

  53. Deferred angioplasty and stenting in primary percutaneous coronary intervention: one step back, two steps forward?

    Article • EuroIntervention, February 2013, Europa Digital & Publishing

    Prof. Giuseppe Biondi-Zoccai, Professor Marco Valgimigli

  54. A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: The AVIO trial

    Article • American Heart Journal, January 2013, Elsevier

    Professor Marco Valgimigli

  55. ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation

    Article • Revista Española de Cardiología (English Edition), January 2013, Elsevier

    Professor Philippe Gabriel STEG, Professor Marco Valgimigli

  56. Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST

    Article • Revista Española de Cardiología, January 2013, Elsevier

    Professor Marco Valgimigli, Professor Felicity Astin, Professor Luigi P. Badano

  57. Letter by Cortese and Valgimigli Regarding Article, “Antithrombotic Therapy in Patients With Chronic Kidney Disease”

    Article • Circulation, November 2012, Wolters Kluwer Health

    Professor Marco Valgimigli

  58. Letter by Vranckx and Valgimigli Regarding Article, “Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention”

    Article • Circulation, October 2012, Wolters Kluwer Health

    Professor Marco Valgimigli

  59. Glycoprotein IIb/IIIa Inhibitors

    Article • October 2012, Wiley

    Professor Marco Valgimigli

  60. TCT-747 Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Professor Marco Valgimigli, Associate Prof Hasan Ari, Dr laurent bonello

  61. TCT-481 Comparison of newer generation drug-eluting stents with bare metal stents in patients with acute ST-segment elevation myocardial infarction: A pooled analysis of EXAMINATION and COMFORTABLE AMI trials

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Professor Marco Valgimigli

  62. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

    Article • The Lancet, October 2012, Elsevier

    Professor Marco Valgimigli

  63. Peri-procedural myocardial infarction and troponism: a quick journey through the land of confusion

    Article • Heart, September 2012, BMJ

    Professor Marco Valgimigli

  64. Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study

    Article • EuroIntervention, August 2012, Europa Digital & Publishing

    Professor Philippe Gabriel STEG, Professor Marco Valgimigli

  65. Drug-Eluting Stent for Left Main Coronary Artery Disease

    Article • JACC Cardiovascular Interventions, July 2012, Elsevier

    Professor Marco Valgimigli

  66. Reply

    Article • JACC Cardiovascular Interventions, June 2012, Elsevier

    Professor Marco Valgimigli

  67. Does the site of bleeding matter? A stratified analysis on Flocation of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction

    Article • EuroIntervention, May 2012, Europa Digital & Publishing

    Professor Marco Valgimigli, Prof. Giuseppe Biondi-Zoccai

  68. Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: The INtegrilin plus STenting to Avoid myocardial Necrosis Trial

    Article • American Heart Journal, May 2012, Elsevier

    Professor Marco Valgimigli, Prof. Giuseppe Biondi-Zoccai

  69. Routine upstream versus selective downstream administration of glycoprotein IIb/IIIa inhibitors in patients with non-ST-elevation acute coronary syndromes: A meta-analysis of randomized trials

    Article • International Journal of Cardiology, March 2012, Elsevier

    Dr Enrico Romagnoli, Professor Marco Valgimigli, Dr Alessandro Sciahbasi, Prof. Giuseppe Biondi-Zoccai

  70. A DOUBLE BLIND RANDOMIZED STUDY TO EVALUATE THE EFFICACY OF BINDARIT IN PREVENTING CORONARY STENT RESTENOSIS

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Marco Valgimigli

  71. Prasugrel Versus Tirofiban Bolus With or Without Short Post-Bolus Infusion With or Without Concomitant Prasugrel Administration in Patients With Myocardial Infarction Undergoing Coronary Stenting

    Article • JACC Cardiovascular Interventions, March 2012, Elsevier

    Professor Marco Valgimigli

  72. COMBINED ANATOMICAL AND CLINICAL FACTORS FOR THE RISK STRATIFICATION OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: THE LOGISTIC CLINICAL SYNTAX SCORE

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Marco Valgimigli

  73. PHARMACODYNAMICS OF VORAPAXAR, A PLATELET PAR-1 ANTAGONIST, AND ITS INTERACTION WITH P2Y12 RECEPTOR PATHWAY IN THE TRACER TRIAL

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Marco Valgimigli

  74. Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

    Article • New England Journal of Medicine, January 2012, New England Journal of Medicine (NEJM/MMS)

    Professor Marco Valgimigli, Professor Giuseppe Ambrosio

  75. Transradial Versus Transfemoral Intervention for Acute Myocardial Infarction

    Article • JACC Cardiovascular Interventions, January 2012, Elsevier

    Professor Marco Valgimigli

  76. Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofib...

    Article • American Heart Journal, January 2012, Elsevier

    Professor Marco Valgimigli

  77. A1M

    Article • January 2012, Springer Science + Business Media

    Professor Marco Valgimigli, prof djillali annane

  78. AAA

    Article • January 2012, Springer Science + Business Media

    Professor Marco Valgimigli, prof djillali annane

  79. AAST Spleen Injury Scale

    Article • January 2012, Springer Science + Business Media

    Professor Marco Valgimigli, prof djillali annane

  80. Abbreviated Injury Scale

    Article • January 2012, Springer Science + Business Media

    Professor Marco Valgimigli, prof djillali annane

  81. Abbreviated Laparotomy

    Article • January 2012, Springer Science + Business Media

    Professor Marco Valgimigli, prof djillali annane

  82. ABCDEs

    Article • January 2012, Springer Science + Business Media

    Professor Marco Valgimigli, prof djillali annane

  83. Abdominal Aortic Aneurysm

    Article • January 2012, Springer Science + Business Media

    Professor Marco Valgimigli, prof djillali annane

  84. Abdominal Aortic Aneurysm: Diagnosis and Management

    Article • January 2012, Springer Science + Business Media

    Professor Marco Valgimigli, prof djillali annane

  85. Reply

    Article • Journal of the American College of Cardiology, December 2011, Elsevier

    Professor Marco Valgimigli

  86. Clinical dilemmas on managing antiplatelet therapies after percutaneous coronary intervention

    Article • Current Opinion in Cardiology, December 2011, Wolters Kluwer Health

    Professor Marco Valgimigli

  87. Dual antiplatelet therapy duration

    Article • Current Opinion in Cardiology, December 2011, Wolters Kluwer Health

    Professor Marco Valgimigli

  88. Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction

    Article • EuroIntervention, December 2011, Europa Digital & Publishing

    Professor Marco Valgimigli

  89. Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe

    Article • EuroIntervention, November 2011, Europa Digital & Publishing

    Professor Marco Valgimigli

  90. Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention

    Article • Journal of the American College of Cardiology, November 2011, Elsevier

    Professor Marco Valgimigli

  91. Early Angio-Guided Complete Revascularization versus Culprit Vessel PCI Followed by Ischemia-Guided Staged PCI in STEMI Patients with Multivessel Disease

    Article • Journal of Interventional Cardiology, October 2011, Wiley

    Professor Marco Valgimigli

  92. Percutaneous coronary intervention versus bypass surgery for left main coronary artery disease: a meta-analysis of randomised trials

    Article • EuroIntervention, October 2011, Europa Digital & Publishing

    Professor Marco Valgimigli

  93. Triple Antiplatelet Therapy in Acute Coronary Syndromes

    Article • Drugs, September 2011, Springer Science + Business Media

    Professor Marco Valgimigli

  94. Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes

    Article • International Journal of Cardiology, August 2011, Elsevier

    Dr Enrico Romagnoli, Professor Marco Valgimigli, Dr Pierfrancesco Agostoni, Prof. Giuseppe Biondi-Zoccai

  95. AMI on the move

    Article • EuroIntervention, August 2011, Europa Digital & Publishing

    Professor Marco Valgimigli

  96. Looking back into the future: desirudin in acute coronary syndromes and coronary stenting

    Article • EuroIntervention, June 2011, Europa Digital & Publishing

    Professor Marco Valgimigli

  97. Prospective Evaluation of On-Clopidogrel Platelet Reactivity Over Time in Patients Treated With Percutaneous Coronary Intervention

    Article • Journal of the American College of Cardiology, June 2011, Elsevier

    Professor Marco Valgimigli

  98. A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials

    Article • JACC Cardiovascular Interventions, June 2011, Elsevier

    Professor Marco Valgimigli

  99. Genetic determinants of on-clopidogrel high platelet reactivity

    Article • Platelets, May 2011, Taylor & Francis

    Professor Marco Valgimigli

  100. Zotarolimus Eluting Stent Clinical Studies

    Article • April 2011, Wiley

    Professor Marco Valgimigli

  101. IMPACT OF CLOPIDOGREL ON-TREATMENT PLATELET REACTIVITY ON STENT THROMBOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A COLLABORATIVE META-ANALYSIS OF INDIVIDUAL PARTICIPANT DATA

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor Marco Valgimigli

  102. Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention

    Article • JACC Cardiovascular Interventions, February 2011, Elsevier

    Professor Philippe Gabriel STEG, Professor Marco Valgimigli

  103. Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease

    Article • Journal of Thrombosis and Thrombolysis, January 2011, Springer Science + Business Media

    Professor Marco Valgimigli

  104. Prediction of 1-Year Clinical Outcomes Using the SYNTAX Score in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

    Article • JACC Cardiovascular Interventions, January 2011, Elsevier

    Professor Marco Valgimigli

  105. Persistent Coronary No Flow After Wire Insertion Is an Early and Readily Available Mortality Risk Factor Despite Successful Mechanical Intervention in Acute Myocardial Infarction

    Article • JACC Cardiovascular Interventions, January 2011, Elsevier

    Professor Marco Valgimigli, Prof. Giuseppe Biondi-Zoccai

  106. Antiplatelet and antithrombotic treatment after primary percutaneous coronary intervention: Balancing safety and efficacy

    Article • American Heart Journal, December 2010, Elsevier

    Professor Marco Valgimigli

  107. Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention

    Article • American Heart Journal, November 2010, Elsevier

    Professor Marco Valgimigli

  108. Long-Term Clinical Outcome Based on Aspirin and Clopidogrel Responsiveness Status After Elective Percutaneous Coronary Intervention

    Article • Journal of the American College of Cardiology, October 2010, Elsevier

    Professor Marco Valgimigli

  109. Balancing safety and efficacy: recent clinical evidence optimizing outcomes in patients with intermediate to high-risk non-ST-segment elevated acute coronary syndrome

    Article • European Heart Journal Supplements, September 2010, Oxford University Press (OUP)

    Professor Marco Valgimigli

  110. Safety evaluation of tirofiban

    Article • Expert Opinion on Drug Safety, July 2010, Informa Healthcare

    Professor Marco Valgimigli

  111. Long-Term Clinical Results Following Stenting of the Left Main Stem

    Article • JACC Cardiovascular Interventions, June 2010, Elsevier

    Professor Marco Valgimigli

  112. Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update

    Article • EuroIntervention, May 2010, Europa Digital & Publishing

    Professor Marco Valgimigli

  113. Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials

    Article • Clinical Research in Cardiology, March 2010, Springer Science + Business Media

    Professor Marco Valgimigli, Roberto Violini

  114. ONE-YEAR OUTCOMES AFTER TIROFIBAN VERSUS ABCIXIMAB INFUSION IN 745 PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY INTERVENTION: INSIGHTS FROM THE MLTISTRATEGY TRIAL

    Article • Journal of the American College of Cardiology, March 2010, Elsevier

    Professor Marco Valgimigli

  115. Poor response to clopidogrel: current and future options for its management

    Article • Journal of Thrombosis and Thrombolysis, February 2010, Springer Science + Business Media

    Professor Marco Valgimigli

  116. Evaluation of Platelet Inhibition by Tirofiban in Patients Stratified According to Aspirin and Clopidogrel Responsiveness

    Article • Journal of the American College of Cardiology, January 2010, Elsevier

    Professor Marco Valgimigli

  117. The 5-Year Clinical Outcomes After a Randomized Comparison of Sirolimus-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction

    Article • Journal of the American College of Cardiology, November 2009, Elsevier

    Professor Marco Valgimigli

  118. Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?

    Article • Journal of Cardiovascular Medicine, October 2009, Wolters Kluwer Health

    Professor Marco Valgimigli

  119. PCV115 TIROFIBAN IS MORE COST-EFFICIENT THAN ABCIXIMAB IN ACHIEVING ST-SEGMENT RESOLUTION FOLLOWING ACUTE MYOCARDIAL INFARCTION

    Article • Value in Health, October 2009, Elsevier

    Professor Marco Valgimigli

  120. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol

    Article • Journal of Cardiovascular Medicine, July 2009, Wolters Kluwer Health

    Professor Marco Valgimigli

  121. Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting

    Article • Clinical and Applied Thrombosis/Hemostasis, June 2009, SAGE Publications

    Professor Marco Valgimigli

  122. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials

    Article • International Journal of Cardiology, April 2009, Elsevier

    Professor Marco Valgimigli, Roberto Violini

  123. Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From 7 Randomized Trials

    Article • Revista Española de Cardiología (English Edition), April 2009, Elsevier

    Professor Marco Valgimigli

  124. Stents liberadores de fármacos frente a stents convencionales en pacientes diabéticos con infarto agudo de miocardio con elevación del segmento ST: un análisis combinado de los datos de pacientes individuales de 7 ensayos aleatorizados

    Article • Revista Española de Cardiología, April 2009, Elsevier

    Professor Marco Valgimigli, Roberto Violini

  125. Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials

    Article • Journal of Thrombosis and Thrombolysis, February 2009, Springer Science + Business Media

    Professor Marco Valgimigli, Roberto Violini

  126. Assisted circulation using the TandemHeart® during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG

    Article • Catheterization and Cardiovascular Interventions, January 2009, Wiley

    Dr E Regar, Professor Marco Valgimigli

  127. Defining the Role of Platelet Glycoprotein Receptor Inhibitors in STEMI

    Article • Drugs, January 2009, Springer Science + Business Media

    Professor Marco Valgimigli

  128. Beneficial Effect of the Nonpeptidyl Low Molecular Weight Radical Scavenger IAC on Cultured Human Islet Function

    Article • Cell Transplantation, October 2008, SAGE Publications

    Professor Marco Valgimigli

  129. A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial

    Article • Journal of Cardiovascular Medicine, September 2008, Wolters Kluwer Health

    Professor Marco Valgimigli, Prof. Giuseppe Biondi-Zoccai, Roberto Violini

  130. A strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction

    Article • International Journal of Cardiology, August 2008, Elsevier

    Professor Marco Valgimigli

  131. Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Unprotected Left Main Coronary Artery Disease: The Endless Debate

    Article • Journal of the American College of Cardiology, August 2008, Elsevier

    Professor Marco Valgimigli

  132. Carotid Stent Cell Design: Lack of Benefit or Lack of Evidence?

    Article • Stroke, August 2008, Wolters Kluwer Health

    Professor Marco Valgimigli

  133. Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol Design

    Article • Cardiovascular Drugs and Therapy, June 2008, Springer Science + Business Media

    Professor Marco Valgimigli

  134. A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial

    Article • Journal of Cardiovascular Medicine, June 2008, Wolters Kluwer Health

    Professor Marco Valgimigli

  135. Longest Available Clinical Outcomes After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease

    Article • Journal of the American College of Cardiology, June 2008, Elsevier

    Professor Marco Valgimigli, Prof. Giuseppe Biondi-Zoccai

  136. Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)

    Article • EuroIntervention, May 2008, Europa Digital & Publishing

    Professor Marco Valgimigli

  137. Comparison of Angioplasty With Infusion of Tirofiban or Abciximab and With Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial InfarctionThe MULTISTRATEGY Randomized Trial

    Article • JAMA, April 2008, American Medical Association (AMA)

    Professor Marco Valgimigli

  138. Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor for Myocardial Recovery After Acute Myocardial Infarction

    Article • Journal of the American College of Cardiology, April 2008, Elsevier

    Professor Marco Valgimigli

  139. Effects of Percutaneous Transluminal Septal Myocardial Ablation for Obstructive Hypertrophic Cardiomyopathy on Systolic and Diastolic Left Ventricular Function Assessed by Pressure–Volume Loops

    Article • The American Journal of Cardiology, April 2008, Elsevier

    Professor Marco Valgimigli

  140. Abciximab: a reappraisal of its use in coronary care

    Article • Biologics Targets & Therapy, March 2008, Dove Medical Press

    Professor Marco Valgimigli

  141. Reply

    Article • Journal of the American College of Cardiology, February 2008, Elsevier

    Professor Marco Valgimigli

  142. Use of granulocyte colony-stimulating factor during acute MI: Fact or fiction?

    Article • Journal of Molecular and Cellular Cardiology, February 2008, Elsevier

    Professor Marco Valgimigli

  143. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease

    Article • American Heart Journal, February 2008, Elsevier

    Professor Marco Valgimigli, Prof. Giuseppe Biondi-Zoccai

  144. Meta-Analysis Appraising High Clopidogrel Loading in Patients Undergoing Percutaneous Coronary Intervention††Conflicts of interest: Dr. Angiolillo is a consultant and on the speaker’s bureau for Bristol Myers Squibb, New York, New York, and Sanofi-Aven...

    Article • The American Journal of Cardiology, October 2007, Elsevier

    Professor Marco Valgimigli, Prof. Giuseppe Biondi-Zoccai, Dr Pierfrancesco Agostoni

  145. Poor Responsiveness to Clopidogrel: Drug-Specific or Class-Effect Mechanism?

    Article • Journal of the American College of Cardiology, September 2007, Elsevier

    Professor Marco Valgimigli

  146. Two-Year Clinical Follow-Up After Sirolimus-Eluting Versus Bare-Metal Stent Implantation Assisted by Systematic Glycoprotein IIb/IIIa Inhibitor Infusion in Patients With Myocardial Infarction

    Article • Journal of the American College of Cardiology, July 2007, Elsevier

    Professor Marco Valgimigli

  147. Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction

    Article • American Heart Journal, July 2007, Elsevier

    Professor Marco Valgimigli

  148. Poor responsiveness to clopidogrel. Drug-specific or class-effect?

    Article • Journal of Molecular and Cellular Cardiology, June 2007, Elsevier

    Professor Marco Valgimigli

  149. Acute coronary syndromes: an emphasis shift from treatment to prevention; and the enduring challenge of vulnerable plaque detection in the cardiac catheterization laboratory

    Article • Journal of Cardiovascular Medicine, April 2007, Wolters Kluwer Health

    Professor Marco Valgimigli, Dr Pierfrancesco Agostoni

  150. Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: Evidence from a meta-regression

    Article • American Heart Journal, April 2007, Elsevier

    Professor Marco Valgimigli, Dr Pierfrancesco Agostoni, Prof. Giuseppe Biondi-Zoccai

  151. Cyphering the Complexity of Coronary Artery Disease Using the Syntax Score to Predict Clinical Outcome in Patients With Three-Vessel Lumen Obstruction Undergoing Percutaneous Coronary Intervention

    Article • The American Journal of Cardiology, April 2007, Elsevier

    Professor Marco Valgimigli

  152. The heart of coronary arteries

    Article • European Heart Journal, March 2007, European Society of Cardiology

    Professor Marco Valgimigli

  153. Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents

    Article • New England Journal of Medicine, March 2007, New England Journal of Medicine (NEJM/MMS)

    Professor Marco Valgimigli

  154. Keeping a high standard in quantitative analyses, meta-analyses, and systematic reviews

    Article • European Heart Journal, February 2007, European Society of Cardiology

    Prof. Giuseppe Biondi-Zoccai, Professor Marco Valgimigli

  155. Clinical Implications of the PROTECT–TIMI-30 Trial

    Article • Journal of the American College of Cardiology, February 2007, Elsevier

    Dr Pierfrancesco Agostoni, Professor Marco Valgimigli, Prof. Giuseppe Biondi-Zoccai

  156. Plaque sealing: Are the benefits outweighing the risks?

    Article • International Journal of Cardiology, February 2007, Elsevier

    Professor Marco Valgimigli, Professor Filippo Cademartiri

  157. Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patients

    Article • International Journal of Cardiology, January 2007, Elsevier

    Professor Marco Valgimigli, Dr Pierfrancesco Agostoni, Prof. Giuseppe Biondi-Zoccai

  158. Plaque Composition in the Left Main Stem Mimics the Distal But Not the Proximal Tract of the Left Coronary Artery

    Article • Journal of the American College of Cardiology, January 2007, Elsevier

    Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  159. Impact of Stable Versus Unstable Coronary Artery Disease on 1-Year Outcome in Elective Patients Undergoing Multivessel Revascularization With Sirolimus-Eluting Stents

    Article • Journal of the American College of Cardiology, January 2007, Elsevier

    Professor Marco Valgimigli

  160. Value of Platelet Reactivity in Predicting Response to Treatment and Clinical Outcome in Patients Undergoing Primary Coronary Intervention

    Article • Journal of the American College of Cardiology, December 2006, Elsevier

    Professor Marco Valgimigli

  161. Diagnostic Performance of Multislice Spiral Computed Tomography of Coronary Arteries as Compared With Conventional Invasive Coronary Angiography

    Article • Journal of the American College of Cardiology, November 2006, Elsevier

    Dr Pierfrancesco Agostoni, Professor Marco Valgimigli, Prof. Giuseppe Biondi-Zoccai

  162. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RE...

    Article • American Heart Journal, November 2006, Elsevier

    Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  163. Stress and tissue Doppler echocardiographic evidence of effectiveness of myoblast transplantation in patients with ischaemic heart failure

    Article • European Journal of Heart Failure, October 2006, Wiley

    Professor Marco Valgimigli

  164. Stem Cell Delivery Modalities

    Article • September 2006, Taylor & Francis

    Professor Marco Valgimigli

  165. Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation

    Article • American Heart Journal, May 2006, Elsevier

    Dr E Regar, Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  166. In vivo relationship between compositional and mechanical imaging of coronary arteries

    Article • American Heart Journal, May 2006, Elsevier

    Dr E Regar, Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  167. Long-Term Outcomes After Stenting of Bifurcation Lesions With the “Crush” Technique

    Article • Journal of the American College of Cardiology, May 2006, Elsevier

    Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  168. Distal Left Main Coronary Disease Is a Major Predictor of Outcome in Patients Undergoing Percutaneous Intervention in the Drug-Eluting Stent Era

    Article • Journal of the American College of Cardiology, April 2006, Elsevier

    Dr E Regar, Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  169. Persistence of Neointimal Growth 12 Months After Intervention and Occurrence of Delayed Restenosis in Patients With Left Main Coronary Artery Disease Treated With Drug-Eluting Stents

    Article • Journal of the American College of Cardiology, April 2006, Elsevier

    Professor Marco Valgimigli

  170. Reproducibility of intravascular ultrasound radiofrequency data analysis: implications for the design of longitudinal studies

    Article • The International Journal of Cardiovascular Imaging, March 2006, Springer Science + Business Media

    Dr E Regar, Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  171. Is Late Luminal Loss an Accurate Predictor of the Clinical Effectiveness of Drug-Eluting Stents in the Coronary Arteries?

    Article • The American Journal of Cardiology, March 2006, Elsevier

    Professor Marco Valgimigli, Dr Pierfrancesco Agostoni, Prof. Giuseppe Biondi-Zoccai

  172. Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure–volume loops

    Article • Nature Clinical Practice Cardiovascular Medicine, March 2006, Springer Science + Business Media

    Professor Marco Valgimigli

  173. Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: Insights from a systematic overview of randomized trials in light of the drug-eluting stent era

    Article • American Heart Journal, March 2006, Elsevier

    Professor Marco Valgimigli, Dr Pierfrancesco Agostoni, Prof. Giuseppe Biondi-Zoccai

  174. Noninvasive Detection of Subclinical Coronary Atherosclerosis Coupled With Assessment of Changes in Plaque Characteristics Using Novel Invasive Imaging Modalities

    Article • Journal of the American College of Cardiology, March 2006, Elsevier

    Professor Marco Valgimigli, Professor Filippo Cademartiri, Nico Bruining, Gaston A Rodriguez-Granillo

  175. Plaque Composition and its Relationship With Acknowledged Shear Stress Patterns in Coronary Arteries

    Article • Journal of the American College of Cardiology, February 2006, Elsevier

    Dr E Regar, Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  176. Sirolimus-Eluting Versus Paclitaxel-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease

    Article • Journal of the American College of Cardiology, February 2006, Elsevier

    Dr E Regar, Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  177. Distance from the ostium as an independent determinant of coronary plaque composition in vivo: an intravascular ultrasound study based radiofrequency data analysis in humans

    Article • European Heart Journal, January 2006, European Society of Cardiology

    Professor Marco Valgimigli

  178. Revisiting late loss and neointimal volumetric measurements in a drug‐eluting stent trial: Analysis from the SPIRIT FIRST trial

    Article • Catheterization and Cardiovascular Interventions, January 2006, Wiley

    Professor Marco Valgimigli, Nico Bruining

  179. Drawbacks of Nonrandomized Trials in Acute Coronary Syndromes

    Article • The American Journal of Cardiology, January 2006, Elsevier

    Dr Pierfrancesco Agostoni, Professor Marco Valgimigli, Prof. Giuseppe Biondi-Zoccai

  180. Tirofiban: a critical reappraisal of the clinical use, recent developments and future perspectives

    Article • Future Cardiology, January 2006, Future Medicine

    Professor Marco Valgimigli

  181. Commentary

    Article • Evidence-based Cardiovascular Medicine, December 2005, Elsevier

    Professor Marco Valgimigli

  182. In Vivo Intravascular Ultrasound-Derived Thin-Cap Fibroatheroma Detection Using Ultrasound Radiofrequency Data Analysis

    Article • Journal of the American College of Cardiology, December 2005, Elsevier

    Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  183. “Full metal jacket” (stented length ≥64 mm) using drug-eluting stents for de novo coronary artery lesions

    Article • American Heart Journal, November 2005, Elsevier

    Dr E Regar, Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  184. Letter Regarding Article by Valgimigli et al, “Short- and Long-Term Clinical Outcome After Drug-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease”

    Article • Circulation, November 2005, Wolters Kluwer Health

    Professor Marco Valgimigli

  185. New and old strategies to afford the liberal use of drug-eluting stents in real-life scenarios

    Article • European Heart Journal Supplements, October 2005, Oxford University Press (OUP)

    Professor Marco Valgimigli

  186. Immediate and One-Year Outcome of Percutaneous Intervention of Saphenous Vein Graft Disease With Paclitaxel-Eluting Stents

    Article • The American Journal of Cardiology, August 2005, Elsevier

    Dr E Regar, Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  187. Comparison of Short- (One Month) and Long- (Twelve Months) Term Outcomes of Sirolimus- Versus Paclitaxel-Eluting Stents in 293 Consecutive Patients With Diabetes Mellitus (from the RESEARCH and T-SEARCH Registries)

    Article • The American Journal of Cardiology, August 2005, Elsevier

    Dr E Regar, Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  188. Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology

    Article • The International Journal of Cardiovascular Imaging, August 2005, Springer Science + Business Media

    Professor Marco Valgimigli, Professor Filippo Cademartiri, Nico Bruining, Gaston A Rodriguez-Granillo

  189. Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy

    Article • International Journal of Cardiovascular Interventions, July 2005, Taylor & Francis

    Professor Marco Valgimigli

  190. Complete myocardial revascularization: between myth and reality

    Article • European Heart Journal, June 2005, European Society of Cardiology

    Professor Marco Valgimigli, Prof. Giuseppe Biondi-Zoccai

  191. Paclitaxel eluting stents for the treatment of angiographically non‐significant atherosclerotic lesions

    Article • International Journal of Cardiovascular Interventions, June 2005, Taylor & Francis

    Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  192. Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous impella recover LP 2.5 assist device during high‐risk coronary intervention

    Article • Catheterization and Cardiovascular Interventions, May 2005, Wiley

    Professor Marco Valgimigli

  193. Tirofiban and Sirolimus-Eluting Stent vs Abciximab and Bare-Metal Stent for Acute Myocardial Infarction

    Article • JAMA, May 2005, American Medical Association (AMA)

    Professor Marco Valgimigli

  194. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile

    Article • European Heart Journal, April 2005, European Society of Cardiology

    Professor Marco Valgimigli

  195. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population

    Article • Journal of the American College of Cardiology, April 2005, Elsevier

    Dr E Regar, Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  196. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance

    Article • The American Journal of Cardiology, March 2005, Elsevier

    Professor Marco Valgimigli, Gaston A Rodriguez-Granillo

  197. Reply

    Article • Journal of the American College of Cardiology, February 2005, Elsevier

    Professor Marco Valgimigli

  198. CD34 + and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure

    Article • Circulation, September 2004, Wolters Kluwer Health

    Professor Marco Valgimigli

  199. The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty

    Article • Journal of the American College of Cardiology, July 2004, Elsevier

    Professor Marco Valgimigli

  200. Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction

    Article • Journal of the American College of Cardiology, June 2004, Elsevier

    Professor Marco Valgimigli

  201. High-Dose BoluS TiRofibAn and Sirolimus Eluting STEnt versus Abiciximab and Bare Metal Stent in Acute MYocardial Infarction (STRATEGY) Study—Protocol Design and Demography of the First 100 Patients

    Article • Cardiovascular Drugs and Therapy, May 2004, Springer Science + Business Media

    Professor Marco Valgimigli

  202. Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress

    Article • Archives of Biochemistry and Biophysics, December 2003, Elsevier

    Professor Marco Valgimigli

  203. Serum From Patients With Acute Coronary Syndromes Displays a Proapoptotic Effect on Human Endothelial Cells

    Article • Circulation, January 2003, Wolters Kluwer Health

    Professor Marco Valgimigli

  204. A Quantitative Approach to the Recycling of α-Tocopherol by Coantioxidants

    Article • The Journal of Organic Chemistry, November 2002, American Chemical Society (ACS)

    Professor Marco Valgimigli

  205. The EPR study of dialkyl nitroxides as probes to investigate the exchange of solutes between micellar and water phases

    Article • Research on Chemical Intermediates, April 2002, Springer Science + Business Media

    Professor Marco Valgimigli

  206. Neurohormonal modulation in chronic heart failure

    Article • European Heart Journal Supplements, April 2002, Oxford University Press (OUP)

    Professor Marco Valgimigli

  207. Neurohormonal modulation in chronic heart failure

    Article • European Heart Journal, April 2002, Elsevier

    Professor Marco Valgimigli

  208. Oxidative Stress EPR Measurement in Human Liver by Radical-probe Technique. Correlation with Etiology, Histology and Cell Proliferation

    Article • Free Radical Research, January 2002, Taylor & Francis

    Professor Marco Valgimigli

  209. Serum Xanthine Oxidase in Human Liver Disease

    Article • The American Journal of Gastroenterology, April 2001, Wolters Kluwer Health

    Professor Marco Valgimigli, MD Maria Giulia Battelli

  210. Left ventricular volumes in liver cirrhosis

    Article • Digestive and Liver Disease, June 2000, Elsevier

    Professor Marco Valgimigli

  211. Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices

    Article • Hepatology, February 2000, Wolters Kluwer Health

    Professor Marco Valgimigli

  212. Measurement of oxidative stress in human liver by EPR spin-probe technique

    Article • Free Radical Research, January 2000, Taylor & Francis

    Professor Marco Valgimigli

  213. Doppler Ultrasound in Portal Hypertension

    Article • January 2000, Springer Science + Business Media

    Professor Marco Valgimigli

  214. Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: A long-term prospective study

    Article • Hepatology, July 1999, Wolters Kluwer Health

    Professor Marco Valgimigli

  215. Splanchnic Arterial Doppler Parameters in Portal Hypertension

    Article • Hepatology, May 1999, Wolters Kluwer Health

    Professor Marco Valgimigli

  216. Do Peroxyl Radicals Obey the Principle That Kinetic Solvent Effects on H-Atom Abstraction Are Independent of the Nature of the Abstracting Radical?

    Article • The Journal of Organic Chemistry, May 1998, American Chemical Society (ACS)

    Professor Marco Valgimigli

  217. Duplex Doppler findings in splenic arteriovenous fistula

    Article • Journal of Clinical Ultrasound, February 1998, Wiley

    Professor Marco Valgimigli

  218. Gallstone ileus in Caroli's disease: Ultrasound diagnosis

    Article • European Journal of Ultrasound, February 1998, Elsevier

    Professor Marco Valgimigli

  219. A case of extracranial vertebral artery dissection with spontaneous recovery

    Article • European Journal of Ultrasound, December 1997, Elsevier

    Professor Marco Valgimigli

  220. IMO 1228 Superior mesenteric artery Doppler impedance indexes in chronic liver diseases

    Article • Ultrasound in Medicine & Biology, January 1997, Elsevier

    Professor Marco Valgimigli

  221. Reactions of Substituted Boryl Radicals with Nitroalkanes. EPR, Kinetic, and Product Studies

    Article • The Journal of Organic Chemistry, January 1996, American Chemical Society (ACS)

    Professor Marco Valgimigli